Key Facts

Invested since 2020
Based in North Rhine-Westphalia

About the company

Resolve Biosciences is creating solutions which offer the power of Molecular Cartography enabling scientists to gain valuable insights at subcellular resolution, across vast numbers of biomolecules (RNA, DNA, proteins) to create three-dimensional maps of molecular activity in living cells.

Do you want to

know more about this company?

Zum Artikel

Dr. Caroline Fichtner Principal

Dr. Caroline FichtnerPrincipal

Resolve Biosciences in the news

resolve logo Zum Artikel

News

28. October 2022

Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography™ Workflow

Zum Artikel

News

11. December 2020

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

More startups from Life Sciences